Cargando…
Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives
SIMPLE SUMMARY: In recent years, the adjuvant treatment of endometrial carcinoma has changed due to the integration of the molecular features in the clinical–pathological classification. The new ESGO/ESTRO/ESP guidelines (2021) proposed the evaluation of the adjuvant treatment of endometrial carcino...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470828/ https://www.ncbi.nlm.nih.gov/pubmed/34571723 http://dx.doi.org/10.3390/biology10090845 |